Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease

Don Poldermans, Paolo M. Fioretti, Eric Boersma, T. Forster, Hero van Urk, Jan H. Cornel, Mariarosaria Arnese, Jos R.T.C.

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

The purpose of this study was to establish the safety of high-dose dobutamine-atropine stress echocardlography in patients with suspected or proven coronary artery disease. Six hundred fifty consecutive examinations were completed. Mean age of patients was 61 years; 300 had a previous myocardial infarction. Heart rate increased from 73 to 129 beats/min during stress testing, blood pressure did not change significantly (from 140/81 to 150/80 mm Hg). Atropine was added to dobutamine in 239 patients when no ischemia was induced with dobutamine alone and the peak heart rate was

Original languageEnglish
Pages (from-to)456-459
Number of pages4
JournalThe American journal of cardiology
Volume73
Issue number7
DOIs
Publication statusPublished - Mar 1 1994

Fingerprint

Stress Echocardiography
Dobutamine
Atropine
Coronary Artery Disease
Safety
Heart Rate
Ischemia
Myocardial Infarction
Blood Pressure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. / Poldermans, Don; Fioretti, Paolo M.; Boersma, Eric; Forster, T.; van Urk, Hero; Cornel, Jan H.; Arnese, Mariarosaria; R.T.C., Jos.

In: The American journal of cardiology, Vol. 73, No. 7, 01.03.1994, p. 456-459.

Research output: Contribution to journalArticle

Poldermans, Don ; Fioretti, Paolo M. ; Boersma, Eric ; Forster, T. ; van Urk, Hero ; Cornel, Jan H. ; Arnese, Mariarosaria ; R.T.C., Jos. / Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. In: The American journal of cardiology. 1994 ; Vol. 73, No. 7. pp. 456-459.
@article{90859e4e1dcd492eaade135fe5130ece,
title = "Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease",
abstract = "The purpose of this study was to establish the safety of high-dose dobutamine-atropine stress echocardlography in patients with suspected or proven coronary artery disease. Six hundred fifty consecutive examinations were completed. Mean age of patients was 61 years; 300 had a previous myocardial infarction. Heart rate increased from 73 to 129 beats/min during stress testing, blood pressure did not change significantly (from 140/81 to 150/80 mm Hg). Atropine was added to dobutamine in 239 patients when no ischemia was induced with dobutamine alone and the peak heart rate was",
author = "Don Poldermans and Fioretti, {Paolo M.} and Eric Boersma and T. Forster and {van Urk}, Hero and Cornel, {Jan H.} and Mariarosaria Arnese and Jos R.T.C.",
year = "1994",
month = "3",
day = "1",
doi = "10.1016/0002-9149(94)90675-0",
language = "English",
volume = "73",
pages = "456--459",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease

AU - Poldermans, Don

AU - Fioretti, Paolo M.

AU - Boersma, Eric

AU - Forster, T.

AU - van Urk, Hero

AU - Cornel, Jan H.

AU - Arnese, Mariarosaria

AU - R.T.C., Jos

PY - 1994/3/1

Y1 - 1994/3/1

N2 - The purpose of this study was to establish the safety of high-dose dobutamine-atropine stress echocardlography in patients with suspected or proven coronary artery disease. Six hundred fifty consecutive examinations were completed. Mean age of patients was 61 years; 300 had a previous myocardial infarction. Heart rate increased from 73 to 129 beats/min during stress testing, blood pressure did not change significantly (from 140/81 to 150/80 mm Hg). Atropine was added to dobutamine in 239 patients when no ischemia was induced with dobutamine alone and the peak heart rate was

AB - The purpose of this study was to establish the safety of high-dose dobutamine-atropine stress echocardlography in patients with suspected or proven coronary artery disease. Six hundred fifty consecutive examinations were completed. Mean age of patients was 61 years; 300 had a previous myocardial infarction. Heart rate increased from 73 to 129 beats/min during stress testing, blood pressure did not change significantly (from 140/81 to 150/80 mm Hg). Atropine was added to dobutamine in 239 patients when no ischemia was induced with dobutamine alone and the peak heart rate was

UR - http://www.scopus.com/inward/record.url?scp=0028327160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028327160&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(94)90675-0

DO - 10.1016/0002-9149(94)90675-0

M3 - Article

C2 - 8141086

AN - SCOPUS:0028327160

VL - 73

SP - 456

EP - 459

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 7

ER -